BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36952398)

  • 21. Factors associated with death and loss to follow-up in children on antiretroviral care in Mingalardon Specialist Hospital, Myanmar, 2006-2016.
    Kaung Nyunt KK; Han WW; Satyanarayana S; Isaakidis P; Hone S; Khaing AA; Nguyen Binh H; Oo HN
    PLoS One; 2018; 13(4):e0195435. PubMed ID: 29621302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for HIV Infection in Asymptomatic, Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Dana T; Grusing S; Bougatsos C
    JAMA; 2019 Jun; 321(23):2337-2348. PubMed ID: 31184705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
    Stringer JS; Zulu I; Levy J; Stringer EM; Mwango A; Chi BH; Mtonga V; Reid S; Cantrell RA; Bulterys M; Saag MS; Marlink RG; Mwinga A; Ellerbrock TV; Sinkala M
    JAMA; 2006 Aug; 296(7):782-93. PubMed ID: 16905784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study.
    European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord
    Clin Infect Dis; 2020 Jan; 70(3):404-415. PubMed ID: 30919882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand.
    Kyaw NL; Thanachartwet V; Kiertiburanakul S; Desakorn V; Chamnanchanunt S; Chierakul W; Manosuthi W; Pitisuttithum P; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2013 Mar; 44(2):232-43. PubMed ID: 23691633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysis.
    Inzaule SC; Kroeze S; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Steegen K; Nankya I; Boender TS; Ondoa P; Sigaloff KCE; de Wit TFR; Hamers RL
    AIDS; 2022 Aug; 36(10):1437-1447. PubMed ID: 35608116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria.
    Ndembi N; Murtala-Ibrahim F; Tola M; Jumare J; Aliyu A; Alabi P; Mensah C; Abimiku A; Quiñones-Mateu ME; Crowell TA; Rhee SY; Shafer RW; Gupta R; Blattner W; Charurat ME; Dakum P
    AIDS Res Ther; 2020 Nov; 17(1):64. PubMed ID: 33143751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
    Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival of people aged 50 years and older by HIV and HIV treatment status: findings from three waves of the SAGE-Wellbeing of Older People Study (SAGE-WOPS) in Uganda.
    Mugisha Okello J; Nash S; Kowal P; Naidoo N; Chatterji S; Boerma T; Seeley J
    AIDS Res Ther; 2020 May; 17(1):17. PubMed ID: 32410634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes in HIV infected patients older than 50 years attending an HIV clinic in Harare, Zimbabwe: A cohort study.
    Shamu T; Chimbetete C; Egger M; Mudzviti T
    PLoS One; 2021; 16(6):e0253000. PubMed ID: 34106989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of HIV-infected patients on potent antiretroviral therapy programs in Togo: risk factors and the fate of these patients.
    Saka B; Landoh DE; Patassi A; d'Almeida S; Singo A; Gessner BD; Pitché PV
    Pan Afr Med J; 2013; 15():35. PubMed ID: 24009811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda.
    Jain V; Byonanebye DM; Amanyire G; Kwarisiima D; Black D; Kabami J; Chamie G; Clark TD; Rooney JF; Charlebois ED; Kamya MR; Havlir DV;
    AIDS; 2014 Sep; 28(15):2241-9. PubMed ID: 25022596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low CD4 Cell Counts Are Associated with Carotid Plaque and Intima-Media Thickness in Virologically Suppressed HIV-Infected Asians Older Than 50 Years.
    Siwamogsatham S; Chutinet A; Vongsayan P; Samajarn J; Putcharoen O; Aponpong T; Hiransuthikul A; Gatechompol S; Han WM; Chattranukulchai P; Kerr SJ; Ruxrungtham K; Avihingsanon A;
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1160-1169. PubMed ID: 31530175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.
    Althoff KN; Buchacz K; Hall HI; Zhang J; Hanna DB; Rebeiro P; Gange SJ; Moore RD; Kitahata MM; Gebo KA; Martin J; Justice AC; Horberg MA; Hogg RS; Sterling TR; Cescon A; Klein MB; Thorne JE; Crane HM; Mugavero MJ; Napravnik S; Kirk GD; Jacobson LP; Brooks JT;
    Ann Intern Med; 2012 Sep; 157(5):325-35. PubMed ID: 22944874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
    PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population-based CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment coverage.
    Malaza A; Mossong J; Bärnighausen T; Viljoen J; Newell ML
    PLoS One; 2013; 8(7):e70126. PubMed ID: 23894603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Site Heterogeneity and HIV Outcomes Across Rural and Urban Study Sites in Phidisa II - A Multi-site Randomized Controlled Antiretroviral Treatment Trial in a South African Military Cohort.
    Steytler J; Shaw PA; Pau AK; Khabo P; Joshi G; Oelofse P;
    Curr HIV Res; 2017; 15(3):178-187. PubMed ID: 28521717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease progression and mortality with untreated HIV infection: evidence synthesis of HIV seroconverter cohorts, antiretroviral treatment clinical cohorts and population-based survey data.
    Glaubius R; Kothegal N; Birhanu S; Jonnalagadda S; Mahiane SG; Johnson LF; Brown T; Stover J; Mangal TD; Pantazis N; Eaton JW
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25784. PubMed ID: 34546644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.